BioTek Instruments, Inc. affirms their ongoing investment across the North American microplate-based technology market with the expansion of their business in Canada. The dedicated sales and support operation will focus on bringing enhanced applications and technical support throughout the country.
Dr. Charles Amirmansour, previously BioTek’s Applications and Business Development Manager, is now appointed as the Canadian Country Manager. “Canada’s Life Science sector continues to yield high-quality scientific research, supported by federal and provincial government focus and investments,” he states. “By expanding our footprint here, we can continue to provide first-in-class local, comprehensive and immediate sales, applications and service support to this rapidly growing market.”
BioTek Instruments, Inc., headquartered in Winooski, VT, USA, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. These technologies are used to aid life science research, facilitate drug discovery, provide rapid and cost-effective analysis, and enable sensitive, accurate quantification of molecules across diverse applications. BioTek espouses a “Think Possible” approach that sets the tone for fresh ideas, unsurpassed customer service and original innovations. As such, they are often honored for local accomplishments and technological innovations, including Best Places to Work in Vermont, North American New Product Innovation Award for Workflow Solutions in Life Sciences and Drug Discovery Product of the Year – Scientists' Choice Award.